A Systematic Review and Meta-analysis on Stenting for Aortic Coarctation Management in Adults.

IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Journal of Endovascular Therapy Pub Date : 2025-06-01 Epub Date: 2023-06-07 DOI:10.1177/15266028231179919
Petroula Nana, Konstantinos Spanos, Alexandros Brodis, George Kouvelos, Carsten Rickers, Rainer Kozlik-Feldmann, Athanasios Giannoukas, Tilo Kölbel
{"title":"A Systematic Review and Meta-analysis on Stenting for Aortic Coarctation Management in Adults.","authors":"Petroula Nana, Konstantinos Spanos, Alexandros Brodis, George Kouvelos, Carsten Rickers, Rainer Kozlik-Feldmann, Athanasios Giannoukas, Tilo Kölbel","doi":"10.1177/15266028231179919","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Endovascular treatment of aortic coarctation (CoA) constitutes a valuable alternative with low morbidity and mortality. The aim of this systematic review and meta-analysis was to assess the technical success, re-intervention, and mortality after stenting for CoA in adults.</p><p><strong>Materials and methods: </strong>The Preferred Reporting Items for Systematic Reviews and Meta-analysis statement and PICO (patient, intervention, comparison, outcome) model were followed. An English literature data search was conducted, using PubMed, EMBASE, and CENTRAL, until December 30, 2021. Only studies reporting on stenting, for native or recurrent CoA, in adults were included. The risk of bias was assessed using the Newcastle-Ottawa Scale. A proportional meta-analysis was performed to assess the outcomes. Primary outcomes were technical success, intra-operative pressure gradient and complications, and 30-day mortality.</p><p><strong>Results: </strong>Twenty-seven articles (705 patients) were included (64.0% males, 34.0±13.6 years). Native CoA was present in 65.7%. Technical success was 97% (95% confidence interval [CI], 0.96%-0.99%; p<0.001, <i>I</i><sup>2</sup>=9.49%). Six (odds ratio [OR]: 1%; 95% CI, 0.00%-0.02%; p=0.002, <i>I</i><sup>2</sup>=0%) ruptures and 10 dissections (OR: 2%; 95% CI, 0.001%-0.02%; p<0.001, <i>I</i><sup>2</sup>=0%) were reported. The intra-operative and 30-day mortality were 1% (95% CI, 0.00%-0.02%; p=0.003, <i>I</i><sup>2</sup>=0%) and 1% (95% CI, 0.00%-0.02%; p=0.004, <i>I</i><sup>2</sup>=0%), respectively. The median follow-up was 29 months. Sixty-eight re-interventions (OR: 8%; 95% CI, 0.05%-0.10%; p<0.001, <i>I</i><sup>2</sup>=35.99%) were performed; 95.5% were endovascular. Seven deaths were reported (OR: 2%; 95% CI, 0.00%-0.03%; p=0.008, <i>I</i><sup>2</sup>=0%).</p><p><strong>Conclusion: </strong>Stenting for CoA in adults presents high technical success and the intra-operative and 30-day mortality rates were acceptable. During the midterm follow-up, the re-intervention rate was acceptable, and mortality was low.Clinical ImpactAortic coarctation is a quite common heart defect that may be diagnosed in adult patients, as a first diagnosis in native cases or as a recurrent after previous repair. Endovascular management using plain angioplasty has been associated to a high intra-operative complication and re-intervention rate. Stenting in this analysis seems to be safe and effective as is related a high technical success rate, exceeding 95%, with a low intra-operative complication and death rate. During the mid-term follow-up, the re-interventions rate is estimated at less than 10% while most cases are managed using endovascular means. Further analyses are needed on the impact of stent type on endovascular repair outcomes.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"548-557"},"PeriodicalIF":1.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028231179919","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Endovascular treatment of aortic coarctation (CoA) constitutes a valuable alternative with low morbidity and mortality. The aim of this systematic review and meta-analysis was to assess the technical success, re-intervention, and mortality after stenting for CoA in adults.

Materials and methods: The Preferred Reporting Items for Systematic Reviews and Meta-analysis statement and PICO (patient, intervention, comparison, outcome) model were followed. An English literature data search was conducted, using PubMed, EMBASE, and CENTRAL, until December 30, 2021. Only studies reporting on stenting, for native or recurrent CoA, in adults were included. The risk of bias was assessed using the Newcastle-Ottawa Scale. A proportional meta-analysis was performed to assess the outcomes. Primary outcomes were technical success, intra-operative pressure gradient and complications, and 30-day mortality.

Results: Twenty-seven articles (705 patients) were included (64.0% males, 34.0±13.6 years). Native CoA was present in 65.7%. Technical success was 97% (95% confidence interval [CI], 0.96%-0.99%; p<0.001, I2=9.49%). Six (odds ratio [OR]: 1%; 95% CI, 0.00%-0.02%; p=0.002, I2=0%) ruptures and 10 dissections (OR: 2%; 95% CI, 0.001%-0.02%; p<0.001, I2=0%) were reported. The intra-operative and 30-day mortality were 1% (95% CI, 0.00%-0.02%; p=0.003, I2=0%) and 1% (95% CI, 0.00%-0.02%; p=0.004, I2=0%), respectively. The median follow-up was 29 months. Sixty-eight re-interventions (OR: 8%; 95% CI, 0.05%-0.10%; p<0.001, I2=35.99%) were performed; 95.5% were endovascular. Seven deaths were reported (OR: 2%; 95% CI, 0.00%-0.03%; p=0.008, I2=0%).

Conclusion: Stenting for CoA in adults presents high technical success and the intra-operative and 30-day mortality rates were acceptable. During the midterm follow-up, the re-intervention rate was acceptable, and mortality was low.Clinical ImpactAortic coarctation is a quite common heart defect that may be diagnosed in adult patients, as a first diagnosis in native cases or as a recurrent after previous repair. Endovascular management using plain angioplasty has been associated to a high intra-operative complication and re-intervention rate. Stenting in this analysis seems to be safe and effective as is related a high technical success rate, exceeding 95%, with a low intra-operative complication and death rate. During the mid-term follow-up, the re-interventions rate is estimated at less than 10% while most cases are managed using endovascular means. Further analyses are needed on the impact of stent type on endovascular repair outcomes.

成人主动脉缩窄支架置入术的系统回顾和荟萃分析。
目的:血管内治疗主动脉缩窄(CoA)是一种低发病率和死亡率的有价值的替代方法。本系统综述和荟萃分析的目的是评估成人CoA支架置入术后的技术成功、再干预和死亡率。材料和方法:采用系统评价和meta分析声明的首选报告项目和PICO(患者、干预、比较、结果)模型。使用PubMed、EMBASE和CENTRAL进行英文文献数据检索,检索时间截止到2021年12月30日。仅纳入了报道成人先天性或复发性CoA支架置入术的研究。偏倚风险采用纽卡斯尔-渥太华量表进行评估。采用比例荟萃分析来评估结果。主要结局为技术成功、术中压力梯度、并发症和30天死亡率。结果:纳入文献27篇(705例),男性64.0%,年龄34.0±13.6岁。65.7%存在原生CoA。技术成功率为97%(95%置信区间[CI], 0.96%-0.99%;皮= 9.49%)。6(优势比[OR]: 1%;95% ci, 0.00%-0.02%;p=0.002, I2=0%)例破裂和10例剥离(OR: 2%;95% ci, 0.001%-0.02%;pI2=0%)。术中死亡率和30天死亡率为1% (95% CI, 0.00%-0.02%;p=0.003, I2=0%)和1% (95% CI, 0.00%-0.02%;p=0.004, I2=0%)。中位随访时间为29个月。68次再干预(OR: 8%;95% ci, 0.05%-0.10%;pI2=35.99%);95.5%为血管内病变。报告了7例死亡(OR: 2%;95% ci, 0.00%-0.03%;I2 = 0%, p = 0.008)。结论:成人CoA支架置入术技术成功率高,术中死亡率和30天死亡率可接受。中期随访期间,再干预率可接受,死亡率低。临床影响性主动脉缩窄是一种非常常见的心脏缺陷,可以在成人患者中诊断出来,作为原生病例的首次诊断或作为先前修复后的复发。使用血管成形术进行血管内管理与高术中并发症和再干预率相关。在这个分析中,支架置入术似乎是安全有效的,因为技术成功率高,超过95%,术中并发症和死亡率低。在中期随访中,再干预率估计不到10%,而大多数病例采用血管内手段进行治疗。需要进一步分析支架类型对血管内修复结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
15.40%
发文量
203
审稿时长
6-12 weeks
期刊介绍: The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信